Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
About Antibiotics
9M India manufactures a comprehensive range of Finished Dosage Form (FDF) antibiotic medicines from a WHO-GMP certified facility in Birkoni, Chhattisgarh. Our antibiotic portfolio spans five dosage forms — tablets, capsules, syrups, suspensions and sterile injections — covering the four major antibiotic classes most demanded in domestic institutional supply and international export markets.

Our antibiotic range includes Penicillins, Macrolides, Fluoroquinolones, Cephalosporins and Tetracyclines — manufactured to the same compliance standard applied to our full export portfolio. Every formulation carries valid DCGI manufacturing approval and is supported by complete regulatory documentation.
Antibiotic manufacturing demands exceptional process discipline — from raw material sourcing and in-process controls through to final batch release. At 9M India, every antibiotic batch is tested in our in-house analytical laboratory before dispatch. No batch is released on third-party testing alone.
For institutional buyers, government procurement programmes and international distributors requiring WHO-GMP FDF antibiotics with full documentation, 9M India is a single-source manufacturing partner.
Our Capabilities
Manufacturing antibiotics at scale demands process consistency, contamination control and documentation discipline that goes beyond standard pharmaceutical manufacturing. Our facility is built for it.
01
9M India produces antibiotic formulations across all major oral and parenteral dosage forms. Oral solid manufacturing — tablets and capsules — covers standard, film-coated, enteric-coated and extended-release formats. Oral liquid manufacturing covers dry syrups, reconstitutable suspensions and ready-to-use syrups with taste-masking for paediatric formulations. Sterile injectable antibiotics are produced in our classified cleanroom environments under aseptic conditions.
02
Antibiotic manufacturing requires strict containment and cross-contamination controls — particularly for Beta-Lactam and Cephalosporin classes which require dedicated manufacturing areas. Our facility maintains the process segregation, environmental monitoring protocols and personnel controls required for safe multi-product antibiotic manufacturing.
03
Every antibiotic batch undergoes full in-house testing before release — including assay, dissolution, microbial limits, related substances and stability-indicating methods. Certificates of Analysis are issued from our own QC laboratory. Antibiotic-specific testing — including potency assays and microbiological testing — is conducted as standard, not on request.
04
Our oral liquid manufacturing includes dedicated capability for paediatric antibiotic formulations — dry syrups for reconstitution, taste-masked suspensions and age-appropriate dosing formats. Paediatric antibiotic supply is a major component of both domestic institutional (NHM, district hospitals) and international (Africa, South Asia) export demand. Our formulations are developed with paediatric dosing, palatability and shelf-life requirements in mind.
05
All antibiotic formulations are supported by complete documentation for institutional tender submission and export registration — Manufacturing Licence, DCGI approvals, WHO-GMP Certificate, COA, COC, stability data and product dossiers. For international buyers requiring dossier filing in regulated and semi-regulated markets, our regulatory team provides complete export documentation support.
Available Dosage Forms
Our antibiotic range is available across every major dosage form — matching the supply requirements of hospital formularies, retail distribution, paediatric care and sterile institutional supply.
Tablets
Capsules
Syrups
Suspensions
Injections
Why Choose Us
Antibiotic buyers — whether institutional procurement officers, international distributors or generic pharma brands — need one thing above all else: a manufacturer they can rely on not to let them down at audit, at tender, or at supply.
Penicillins, Macrolides, Fluoroquinolones, Cephalosporins and Tetracyclines — across tablets, capsules, syrups, suspensions and injections. No need to split your antibiotic portfolio across multiple suppliers.
The same manufacturing standard we apply to export supply across 15+ countries applies to every domestically supplied antibiotic batch. There is no separate lower-tier production line.
DCGI approvals, WHO-GMP certificate, COA from our in-house lab, stability data, dossiers — pre-prepared for tender submission and export registration. Antibiotic procurement failures happen at documentation stage. Ours don't.
Our Antibiotics Range
A selection of antibiotic molecules from our manufacturing portfolio — across classes, dosage forms and therapeutic applications.
Amoxicillin Class: Penicillin Forms: Tablets · Capsules · Dry syrup · Suspension Use: Broad-spectrum bacterial infections
Azithromycin Class: Macrolide Forms: Tablets · Capsules · Dry syrup Use: Respiratory, skin and soft tissue infections
Ciprofloxacin Class: Fluoroquinolone Forms: Tablets · Capsules · Injection (IV) Use: UTI, respiratory, GI and systemic infections
Cephalexin Class: Cephalosporin (1st gen) Forms: Tablets · Capsules · Suspension Use: Skin, respiratory and urinary tract infections
Cefuroxime Class: Cephalosporin (2nd gen) Forms: Tablets · Dry syrup Use: Respiratory and ENT infections
Cefixime Class: Cephalosporin (3rd gen) Forms: Tablets · Dry syrup · Suspension Use: Typhoid, UTI, ENT and respiratory infections
Ceftriaxone Class: Cephalosporin (3rd gen) Forms: Dry powder injection Use: Severe systemic and hospital-acquired infections
Doxycycline Class: Tetracycline Forms: Tablets · Capsules Use: Respiratory, skin and intracellular infections
Metronidazole Class: Nitroimidazole Forms: Tablets · Suspension · Injection Use: Anaerobic bacterial and protozoal infections
Co-amoxiclav Class: Penicillin + Beta-lactamase inhibitor Forms: Tablets · Dry syrup · Suspension Use: Resistant bacterial infections — ENT, respiratory, skin
Levofloxacin Class: Fluoroquinolone Forms: Tablets · Injection Use: Community-acquired pneumonia, UTI, skin infections
Cefdinir Class: Cephalosporin (3rd gen) Forms: Tablets · Suspension Use: ENT, skin and respiratory infections
We keep answer short
01
9M India manufactures Finished Dosage Form (FDF) antibiotics across five major classes — Penicillins, Macrolides, Fluoroquinolones, Cephalosporins (1st, 2nd and 3rd generation) and Tetracyclines. Our antibiotic portfolio is available across tablets, capsules, syrups, suspensions and sterile injections.
02
Yes. All antibiotic formulations manufactured at 9M India carry valid DCGI manufacturing licences and product approvals. Complete regulatory documentation — including manufacturing licence, product approvals, WHO-GMP certificate and stability data — is available for review and submission.
03
Yes. Our oral liquid manufacturing includes dedicated paediatric antibiotic formulations — dry syrups for reconstitution, taste-masked suspensions and age-appropriate dosing formats. Key paediatric antibiotic formulations include Amoxicillin dry syrup, Azithromycin dry syrup, Cefixime suspension and Co-amoxiclav suspension.
04
Yes. 9M India has strong experience in institutional and government antibiotic supply — including state tender programmes, NHM supply, CGHS and ESIC procurement. Our antibiotic formulations are DCGI-approved and our documentation package is pre-prepared for tender bid submission.
05
Yes. Our sterile manufacturing facility produces injectable antibiotic formulations in dry powder injection and vial liquid formats — including Ceftriaxone dry powder injection, Ampicillin and Ciprofloxacin IV. All injectable antibiotics are manufactured in classified cleanroom environments with full sterility and endotoxin testing on every batch.
Share your requirement - product availability, documentation and lead times confirmed within 24 hours.